1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Recurrent Grade 2 Follicular Lymphoma: new trials by email Literature Review of Recurrent Grade 2 Follicular Lymphoma trials Research Report on Recurrent Grade 2 Follicular Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Cyclophosphamide and Rituximab, Filgrastim, Chemotherapy or Radiation therapy - Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma | Phase 2 / Phase 3 | Terminated | Medical College of Wisconsin | 30 | 2004-08-01 | 2023-01-05 |
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Carmustine (1) · Cyclophosphamide (1) · Drug Therapy (1) · Etoposide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Methotrexate (1) · Radiotherapy (1) · Rituximab (1) · Tacrolimus (1) · Transplantation, Autologous (1) · Transplantation, Homologous (1) · fludarabine (1) · fludarabine phosphate (1)
Medical College of Wisconsin (1)
United States (1)
U01HL069294 (1), U24CA076518 (1)